✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹778 Cr.
P/E
18.96

Key Ratios

Market cap
Market cap
778 Cr
PE
PE
18.96
Prom Holding
Prom Holding
71.80 %
ROE (%)
ROE (%)
14.52
ROCE (%)
ROCE (%)
19.09
Div Yield (%)
Div Yield (%)
1.93
Sales
Sales
771 Cr
OPM (%)
OPM (%)
7.63 %
Debt to Equity
Debt to Equity
0.03
Institutions
Institutions
0.05 %
Individual < 2 lac
Individual < 2 lac
17.03 %
No. of Shareholders
No. of Shareholders
27,425

About

Anuh Pharma Ltd is one of the leading manufacturers of Active Pharmaceutical Ingredients (API… Read more
Low
67
52W Range
High
115
  • Anuh Pharma
  • Kilitch Drugs(India)
  • Bharat Parenterals
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

Edit rows

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

22 %
(as of Mar 22)
Chloramphenicol - Market Share
7 %
(as of Mar 22)
Corticosteroids - Market Share
18 %
(as of Mar 22)
Erythromycin - Market Share
2 %
(as of Mar 22)
Higher Macrolides(Azithromycin)
33 %
(as of Mar 22)
Pyrazinamide - Market Share
12.50 %
(as of Mar 22)
Sulfaxoxine

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Brand Wise Break-Up

Operational Metrics

    Select a Metric
    • R&D as a % of Total Sales (%)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Anuh Pharma Ltd. Business

    Anuh Pharma Ltd is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and also deals in bulk drugs, chemicals, and pharmaceutical formulations.

    Anuh Pharma major competitors are Bharat Parenterals, Wanbury, Kilitch Drugs(India), Zim Laboratories, Jenburkt Pharma, Prevest Denpro, Albert David.
    Market Cap of Anuh Pharma is ₹816 Crs.
    While the median market cap of its peers are ₹595 Crs.

    Anuh Pharma seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material